Opioid MDL Judge Affirms Disqualification Of Endo Attorney, Law Firm

(April 9, 2019, 2:52 PM EDT) -- CLEVELAND — The Ohio federal judge overseeing the opioid multidistrict litigation on April 8 affirmed his March 19 order disqualifying counsel for Endo Pharmaceuticals Inc. in two cases because an attorney had access to confidential, nonpublic information related to the opioid crisis while she was a U.S. attorney (In Re:  National Prescription Opiate Litigation, MDL Docket No. 2804, No. 17-md-2804, N.D. Ohio, Eastern Div., 2019 U.S. Dist. LEXIS 59822)....

Attached Documents

Related Sections